Cargando…

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption

Osteoporosis is characterized by low bone mass associated with bone fragility and high fracture risk resulting in reduced quality of life and a higher mortality rate. Osteoporosis is a result of unbalanced bone remodeling with increased catabolic actions of osteoclasts. To date, mechanisms of coupli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arlt, Heike, Mullarkey, Tara, Mitlak, Bruce, Lanske, Beate, Besschetnova, Tatiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554859/ http://dx.doi.org/10.1210/js.2019-OR03-2

Ejemplares similares

Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice()
por: Arlt, Heike, et al.
Publicado: (2020)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats
por: Teguh, Dian A, et al.
Publicado: (2020)

OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
por: He, Zhiming, et al.
Publicado: (2022)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

MON-365 Novel Use of Abaloparatide to Augment Spinal Fusion in Patient Undergoing Cervicothoracic Revision Surgery
por: Parikh, Sahil, et al.
Publicado: (2020)

ODP118 PTH (1-34) Replacement Therapy for Hypoparathyroidism due to Sporadic Calcium Sensing Receptor Gain-of-Function Point Mutation
por: Basina, Marina, et al.
Publicado: (2022)

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling
por: Winzenrieth, Renaud, et al.
Publicado: (2020)

PSAT156 Abaloparatide Implementation and Follow-Up: Real-World Results of a Pharmacist-Run Anabolic Osteoporosis Clinic
por: Arceri, Veronica, et al.
Publicado: (2022)

Therapeutic Potentials of Dimeric (Cys25)PTH(1–34) Peptide for Osteoporosis and Fracture Healing of the Bones- Buy One, Get One Free
por: Park, Doori, et al.
Publicado: (2021)

Improving the Accuracy and Reliability of Parathyroid Hormone Levels Through the Mass-Spectrometric Measurement of Full-length PTH and C-Terminal PTH Fragments
por: Ulmer, Candice Z, et al.
Publicado: (2021)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

SAT236 Pharmacokinetics (PK) And Pharmacodynamics (PD) Of The Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered Via An Orally Administered Robotic Pill (RT-102)
por: Horlen, Kyle, et al.
Publicado: (2023)

MON-538 Ca(2+)Allostery in PTH-Receptor Signaling
por: White, Alex, et al.
Publicado: (2019)

Ectopic Intact PTH Secretion Causing Humoral Hypercalcemia of Malignancy
por: Rauf, Mohammad Talha, et al.
Publicado: (2021)

PTH Protects Osteocytes From Oxidative Stress and Cellular Senescence
por: Uda, Yuhei, et al.
Publicado: (2021)

Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats
por: Arlt, Heike, et al.
Publicado: (2020)

OR30-3 Structural Basis of Activation and Sustained Signaling by the PTH Receptor
por: Sutkeviciute, Ieva, et al.
Publicado: (2019)

MON-343 The Mystery of Recurrent PTH-Independent Hypercalcemia with Severe Hypophosphatemia
por: Shaikh, Bilal, et al.
Publicado: (2020)

A Curious Case of PTH Independent Hypercalcemia Secondary to Silicone Injections
por: Matos, Moises, et al.
Publicado: (2021)

SAT-402 Investigating Analogues of Parathyroid Hormone (PTH) and PTH-Related Peptide (PTHrP) to Improve Anabolic: Catabolic Response Ratios Using UMR106-01 Osteocytic Cells
por: Oladapo, Oladipo Posi, et al.
Publicado: (2020)

Rare Case of Severe Hypocalcemia Due to PTH Resistance Related to Diet Pill
por: Katkar, Rujuta Baban, et al.
Publicado: (2021)

SAT211 PTH-secreting Endometrial Carcinoma: A Rare Cause of Hypercalcemia
por: Fanous, Ereeny, et al.
Publicado: (2023)

THU393 An Internal NPT2A Cryptic PDZ Motif Is A Novel Regulator of PTH- And FGF23-sensitive Phosphate Transport
por: Sneddon, Bruce W, et al.
Publicado: (2023)

MON-534 Reduced PTH Levels in Adolescents with Anorexia Nervosa: Implication for Kidney and Bone
por: Lenherr-Taube, Nina, et al.
Publicado: (2019)

SAT-503 A Rare Case of Hypercalcemia Due to PTH Secreting Lung Adenocarcinoma
por: Gonzalez-Falero, Andrea, et al.
Publicado: (2019)

SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020)

SAT-388 Dry Cough as Only Sign of a Parathyroid Adenoma Producer of PTH
por: Selman-Geara, Antonio, et al.
Publicado: (2020)

Treatment-Resistant Hypercalcemia Secondary to Ectopic PTH Hypersecretion From Disseminated Ovarian Cancer
por: Balinski, Alexander M, et al.
Publicado: (2021)

SAT195 A Curious Case Of Severe Reversible PTH-mediated Hypercalcemia Of Pregnancy
por: Albanese, Isabella, et al.
Publicado: (2023)

THU474 Primary Hyperaldosteronism As A Cause Of PTH Elevation After Parathyroid Surgery
por: Thi, Wai Phyo, et al.
Publicado: (2023)

SAT-519 Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture Representative of Covered Commercial Insurance Enrollees
por: Saag, Kenneth, et al.
Publicado: (2019)

MON-533 Irisin in Post-Menopausal Women with Primary Hyperparathyroidism: An Interplay between Irisin and Pth
por: Palermo, Andrea, et al.
Publicado: (2019)

SAT-492 Intact PTH Secretion from Hepatocellular Carcinoma in a Patient Presenting with Hypercalcemia
por: Weaver, Anne, et al.
Publicado: (2019)

Follicle-Stimulating Hormone Does Not Impact RANKL-Induced Osteoclastogenesis
por: Zhou, Ziyue, et al.
Publicado: (2021)

OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure
por: Lo, Joan, et al.
Publicado: (2019)

SAT235 An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study
por: Myers, Joshua T, et al.
Publicado: (2023)

SAT-494 A Very Rare Case: Hypercalcemia Caused by Ectopic PTH Secretion in Endometrial Cancer
por: Batarseh, Nour, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v3k22mq71kcd2jie2d7u782ocv